ARCHIVES

Report: Rising Treatment Costs Due to 340B Discounts

This article is from The Cancer Letter archive.

Vol. 40 No. 20 | May 16, 2014

Download PDF Visit The Full Archive

Related Articles

Also ASCO to release abstracts to members prior to annual meeting.

January 30, 2004

NY Attorney General Subpoenaes Amgen, J&J Over ESA Promotion.

May 25, 2007

INSPIRE Enrollment Stopped; Thromboembolism Risk Cited

February 25, 2011

FDA Throws Up IND Roadblock, Then Refuses To Answer Investigator’s Letters About It

February 6, 1976

Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC

December 19, 2014

Working Group To Review NCI Clinical Trials Programs

April 12, 1996